- Home
- LRHC vs GTBP Comparison
LRHC vs GTBP Comparison
Compare LRHC & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- GTBP
- Stock Information
- Founded
- LRHC 2004
- GTBP 1965
- Country
- LRHC United States
- GTBP United States
- Employees
- LRHC N/A
- GTBP N/A
- Industry
- LRHC
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- GTBP Health Care
- Exchange
- LRHC Nasdaq
- GTBP Nasdaq
- Market Cap
- LRHC 5.6M
- GTBP 5.5M
- IPO Year
- LRHC 2023
- GTBP N/A
- Fundamental
- Price
- LRHC $0.13
- GTBP $2.68
- Analyst Decision
- LRHC
- GTBP Strong Buy
- Analyst Count
- LRHC 0
- GTBP 1
- Target Price
- LRHC N/A
- GTBP $11.00
- AVG Volume (30 Days)
- LRHC 5.7M
- GTBP 86.4K
- Earning Date
- LRHC 05-29-2025
- GTBP 05-15-2025
- Dividend Yield
- LRHC N/A
- GTBP N/A
- EPS Growth
- LRHC N/A
- GTBP N/A
- EPS
- LRHC N/A
- GTBP N/A
- Revenue
- LRHC $73,874,281.00
- GTBP N/A
- Revenue This Year
- LRHC N/A
- GTBP N/A
- Revenue Next Year
- LRHC N/A
- GTBP N/A
- P/E Ratio
- LRHC N/A
- GTBP N/A
- Revenue Growth
- LRHC 90.36
- GTBP N/A
- 52 Week Low
- LRHC $0.09
- GTBP $1.72
- 52 Week High
- LRHC $3.36
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- LRHC 44.67
- GTBP 56.17
- Support Level
- LRHC $0.11
- GTBP $2.56
- Resistance Level
- LRHC $0.18
- GTBP $2.82
- Average True Range (ATR)
- LRHC 0.01
- GTBP 0.30
- MACD
- LRHC 0.00
- GTBP 0.01
- Stochastic Oscillator
- LRHC 32.10
- GTBP 65.12
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.